Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection

BACKGROUND: SARS-CoV-2 has caused over 36,000,000 cases and 1,000,000 deaths globally. Comprehensive assessment of the multifaceted anti-viral antibody response is critical for diagnosis, differentiation of severe disease, and characterization of long-term immunity. Initial observations suggest that...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:bioRxiv
Główni autorzy: Haddad, Natalie S., Nguyen, Doan C., Kuruvilla, Merin E., Morrison-Porter, Andrea, Anam, Fabliha, Cashman, Kevin S., Ramonell, Richard P., Kyu, Shuya, Saini, Ankur Singh, Cabrera-Mora, Monica, Derrico, Andrew, Alter, David, Roback, John D., Horwath, Michael, O’Keefe, James B., Wu, Henry M., Ian Wong, An-Kwok, Dretler, Alexandra W., Gripaldo, Ria, Lane, Andrea N., Wu, Hao, Lee, Saeyun, Hernandez, Mindy, Engineer, Vanessa, Varghese, John, Le, Sang, Sanz, Iñaki, Daiss, John L., Eun-Hyung Lee, F.
Format: Artigo
Język:Inglês
Wydane: Cold Spring Harbor Laboratory 2020
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724666/
https://ncbi.nlm.nih.gov/pubmed/33299998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.12.04.410589
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy